No relationship of I1- and I2-imidazoline binding sites to inhibitory effects of imidazolines on ligand-gated ion channels. An investigation in the adrenal medulla and in neuroblastoma cells.
Molderings
G J
GJ
Institute of Pharmacology and Toxicology, University of Bonn, Germany.
Ruppert
K
K
Bönisch
H
H
Göthert
M
M
D000313:Adrenal Medulla / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D002837:Chromaffin Granules / Q000187:drug effects / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology*; D054755:Imidazoline Receptors; D015640:Ion Channel Gating; D007473:Ion Channels / Q000187:drug effects* / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism* / Q000473:pathology; D011869:Radioligand Assay; D011955:Receptors, Drug / Q000187:drug effects* / Q000378:metabolism
D007093:Imidazoles; D054755:Imidazoline Receptors; D007473:Ion Channels; D011955:Receptors, Drug